ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J01DH02 | G | Meropenem - 0.5g | 10926 | 50722/1 | AROPEM | 0.5g | 1 | Injectable sterile lyophilised powder for solution | Infusion/IV | Raymond Georges Abou Adal & Co | ACS Dobfar SpA, Italy for Arwan Pharmaceutical Industries Lebanon SAL | Lebanon | 479,459 L.L | 23.08 | A2 | 2/1/2023 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J01DH02 | G | Meropenem - 500mg | 8143 | 186824/14 | ARCHIFAR | 500mg | 10 | Injectable powder for solution | Infusion | New Allpharma | Medochemie Ltd | Cyprus | 5,478,720 L.L | 21.26 | C | Medochemie Ltd | Cyprus | 2/1/2023 |
J01DH02 | G | Meropenem (trihydrate) - 0.5g | 6893 | 96606/12 | AROPEM | 0.5g | 1 | Injectable powder for solution | Infusion/IV | Raymond Georges Abou Adal & Co | Zambon Switzerland Ltd Switzerland for Arwan Pharmaceutical Industries Lebanon SAL | Lebanon | 479,459 L.L | 23.08 | A2 | 2/1/2023 | ||
J01DH02 | G | Meropenem - 0.5g | 10904 | 158619/1 | AROPEM | 0.5g | 1 | Injectable powder for solution | Infusion/IV | Raymond Georges Abou Adal & Co | Savior Lifetec Corporation, Taiwan for Arwan Pharmaceutical Industries Lebanon SAL | Lebanon | 479,459 L.L | 23.08 | A2 | 2/1/2023 | ||
J01DH02 | B | Meropenem (trihydrate) - 500mg | 10189 | 105419/1 | MERONEM | 500mg | 10 | Injectable powder for solution | Infusion/IV | Droguerie Fattal S.A.L. | ACS Dobfar S.P.A. | Italy | 9,991,850 L.L | 19.35 | D | Pfizer Ltd | UK | 2/1/2023 |